The Venture Collective.
Empowering Founders Who Are
Transforming Legacy Industries
Who We Are.
TVC is a transformational, early-stage venture firm backed by world class
entrepreneurs and business leaders. We invest our capital, time, and network
into highly defensible, fast-growing companies with the potential to solve the world's biggest problems.
What Gets Us Excited.
Ensure people live longer, healthier lives.
- Data-powered software for personalized care delivery
- Novel modalities and platform therapeutics
- AI-driven discovery and repurposing engines
- CPG within deeply underserved TAMs built with novel formulations
On a planet that can stand the test of time.
- Next generation Ag & Farming innovation, leveraging computer vision and AI
- Sustainable materials, chemicals and industrials
- Computing advancement
- Aerospace & Defense
In a society where innovation reaches everyone.
- Digital infrastructure for consumer / SMB enablement
- Human advancement through vertically applied AI
The TVC Approach.
- We invest early with conviction.
- We personalize our support to help companies traverse the Valley of Death. (Read More)
- We double down based on milestones, not time.
- We are your most founder-aligned investor.
Our Team.
Nicholas Shekerdemian
Founding Partner - 2x Founder: Headstart (exit), Teaching by the Top
- Thiel Fellow & YC, Summer 2017
- 60+ Angel Investments
Nicole Seligman
Executive in Residence - Board Member, OpenAI and Intuitive Machines
- Former Board Member, WPP and Paramount
- President, Sony Corporation of America
- Partner, Williams & Connolly LLP
Ines Ullmo
Associate - Venture Fellow, BlueYard Capital
- PhD, Cancer Immunotherapy and Immunology, Imperial College London
Pete Ondishin
Chief Financial Officer - CFO, Kingstown Capital
- Assistant Controller, Atlantic Investment Management
- Assurance Senior Associate, PwC
Gina Shekerdemian
Founding Partner - Director, BlackRock
- Forbes 30 Under 30
- Yale University Advisory Board
Stephanie Sarelakos
Partner - Founding Member, Walmart eCommerce Incubator
- Senior Manager, Jet.com
- Financial Markets Advisory, BlackRock
Emily Aronin
Associate - Senior Investment Analyst, Valor Equity Partners
- Commercial Development, Evozyne
Elliot Richmond
Senior Advisor - Partner, Moelis & Co
- Director, Investment Banking, Merrill Lynch
- 70+ angel investments
Cat Middleton
General Partner - Partner, Primary Ventures
- Head of Due Diligence, PeopleTech Partners
- VP People, Chartbeat
Chris Ghadban
Principal - Principal, Alix Ventures
- Strategy & Innovation, AstraZeneca
- MS, Bioengineering, Tufts University
Luke Lloyd-Davies
Chairman - Managing Director, Sir Elton John and David Furnish’s Global Private Office
- COO, Rocket Entertainment Group
- Advisor, MetroBank
Paula Sutter
Senior Advisor - CEO, TSG Fashion Group
- President, Diane von Furstenberg
- thredUP Board Member
Our Portfolio.
The TVC team has a track record of backing founders building purpose-driven businesses alongside world class investors. Some companies include:
Leveraging synthetic biology to develop mRNA therapeutics for the world's most deadly cancers and diseases.
HelixNano Website
Missions to the International Space Station today. The world’s first commercial space station tomorrow.
Axiom Space Website unicorn
Unlocking the potential of macrocycle drug discovery through machine learning and massively parallel synthesis.
Unnatural Products Website
Venture Partners.
A global network of founders, operators, and investors who expand our experienced core team's ability to source and support TVC's growing portfolio of companies.
In Case You Missed It.
The latest and greatest from the TVC team and our portfolio.
Green Queen
Fork & Good Acquires Orbillion to Take Cultivated Red Meat Platform Global
Fork & Good has acquired Orbillion Bio to merge their B2B-cultivated-meat platforms, combining Fork & Good's pork focus with Orbillion's beef expertise, expanding into Europe and the Middle East, and forming one of the largest IP portfolios in the industry.
Read More
Forbes
How A Healthcare Expert Network Is Powering Startup Growth
MDisrupt accelerates healthcare startup growth by connecting founders with leading medical experts who provide strategic guidance, clinical credibility, and faster market access.
Read More
PR Newswire
Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery
Caravel Bio is launching the first unified platform for protein discovery and delivery, combining cell-free synthesis, bacterial spore display, and machine learning to develop novel protein chemistries for DNA synthesis, animal health and sustainable manufacturing.
Read More